{"id":"W4313891690","doi":"10.2217/fon-2022-0898","title":"Many People with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Benefit From Ibrutinib Treatment up to 8 Years: A Plain Language Summary","year":2022,"lang":"en","type":"review","venue":"Future Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Baker Hughes (Canada); University of Calgary","funders":"Pharmacyclics","keywords":"Ibrutinib; Medicine; Chlorambucil; Chronic lymphocytic leukemia; Internal medicine; Clinical trial; Oncology; Lymphoma; Leukemia; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0005625973,0.001897807,0.006577516,0.00108765,0.0003253258,0.0001165904,0.001457148,0.001728292,0.00678429],"category_scores_gemma":[0.000198507,0.001343964,0.001157179,0.002115662,0.0002450084,0.00009526211,0.001063736,0.0008836999,0.00171575],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.698003,"about_ca_system_score_gemma":0.3480107,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.01765465,"about_ca_topic_score_gemma":0.02264578,"domain_scores_codex":[0.9914799,0.0007077576,0.001502794,0.002638156,0.001338982,0.002332373],"domain_scores_gemma":[0.9925386,0.002288385,0.0007630179,0.002946791,0.0001136778,0.001349507],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.004352526,0.0002095888,0.000002450643,0.007332665,0.002506685,0.02192564,0.003121567,0.00006648032,0.000004650308,0.00007060212,0.009952565,0.9504546],"study_design_scores_gemma":[0.04616347,0.009660413,0.00001817774,0.005694063,0.004369237,0.009785762,0.001243595,0.0005440733,0.000008839702,0.000004829369,0.9212582,0.001249416],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0119756,0.9745836,0.00001181957,0.0001553401,0.002131713,0.006597911,0.001038048,0.0004758691,0.00303005],"genre_scores_gemma":[0.0001335048,0.9545133,0.0008886671,0.0007779888,0.005768875,0.004354442,0.004502121,0.0006338091,0.02842732],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9492052,"threshold_uncertainty_score":0.9995677,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04235839675099185,"score_gpt":0.3464954461082819,"score_spread":0.3041370493572901,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}